Cochlear | COH - Operating Expenses

Stock Price
192.94
Daily Change
-2.46 -1.26%
Monthly
-30.07%
Yearly
-27.74%
Q1 Forecast
194.59

Cochlear reported AUD460.1M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Ansell USD 414.45M 55.9M Jun/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Cochlear AUD 460.1M 437.1M Jun/2025
CSL USD 2.87B 2.85B Jun/2025
Fisher Paykel Healthcare NZD 802.4M 24.1M Dec/2025
Healius AUD 684.9M 261.2M Dec/2024
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Mesoblast USD 56.15M 32.57M Jun/2025
Monash IVF AUD 57.87M 54.74M Jun/2025
Nanosonics AUD 47.22M 37.68M Jun/2025
Polynovo AUD 27.51M 19.08M Jun/2024
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
Regis Healthcare AUD 529.66M 22.28M Dec/2024
ResMed USD 922.51M 49.28M Dec/2025
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Somnomed AUD 47.82M 4.98M Jun/2023
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025